Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Pedestrian Killed in Crash at North Gene Autry Trail and East Vista Chino


Vehicle Hits Person in Fatal Palm Springs Accident 

accidentnews3

Palm Springs, CA (April 14, 2020) – A pedestrian was killed in a crash in Palm Springs. The fatal accident occurred on the afternoon of April 14 at Gene Autry Trail and Vista Chino.

A pedestrian was hit by a vehicle at the intersection. The victim died in the crash. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Palm Springs

#92262


October 28, 2019

Pedestrian Killed in Crash on Del Amo Boulevard

CHP Motorcycle Officer Hits Victim in Fatal Long Beach Accident...


November 7, 2019

Jonathan Rosete Killed, 1 Injured in Crash on Highway 80 Near Currey Road

2 Vehicles Collide in Fatal Dixon Accident...


February 21, 2020

Woman Killed, 2 Injured in Crash at Zediker and Dinuba Avenues

2 Vehicles Collide in Fatal Parlier Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.